TRAVANTI PHARMA INC has a total of 39 patent applications. Its first patent ever was published in 1999. It filed its patents most often in China, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, pharmaceuticals and environmental technology are TRANSCUTANEOUS TECH INC, IOMED INC and MOWER MORTON M.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Australia | 4 | |
#5 | United States | 4 | |
#6 | Canada | 3 | |
#7 | Japan | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Argentina | 2 | |
#10 | Brazil | 2 | |
#11 | Mexico | 2 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Packaging and shipping | |
#5 | Civil engineering | |
#6 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Morris Russell L | 26 |
#2 | Anderson Carter R | 26 |
#3 | Sembrowich Walter L | 8 |
#4 | Krinke Todd A | 7 |
#5 | Cohen Robert | 6 |
#6 | Eischen Kathleen A | 6 |
#7 | Anderson Clayton J | 4 |
#8 | Grace Lori A | 2 |
#9 | Robert Cohen | 1 |
#10 | Todd A Krinke | 1 |
Publication | Filing date | Title |
---|---|---|
CN102202728A | Iontophoretic drug delivery packaging | |
MX2011002373A | Sacrificial electrode design and delivery species suitable for prolonged iontophoresis application periods. | |
US2008114284A1 | Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions | |
US2006253061A1 | Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis | |
US2005163717A1 | Abuse potential reduction in abusable substance dosage form |